Sotio Biotech Is A Czech Biotechnology Company Founded In 2010 And Part Of The Ppf Group Since 2012Headquartered In Praguethe Company Operates Globally With Additional Locations In Europenorth Americaand Asiaunder The Leadership Of Ceo Radek A Pa Aieksotio Focuses On Developing Innovative Cancer Treatmentsparticularly In The Field Of Immunotherapy The Company Has A Diverse Pipeline That Includes Immunocytokines Designed To Activate Immune Cells In Tumorsproprietary Car T Therapies Aimed At Enhancing T Cell Functionand Advanced Antibody Drug Conjugatesadcsfor Cancer Treatmentsotio Also Utilizes Its Boxr Cell Therapy Platform To Improve Engineered T Cell Functionalityresearch And Development Are Conducted In Its Laboratories In Prague And Beijingwith Collaborations Involving Leading Research Institutions And Hospitals In The Us And Europesotio Is Committed To Becoming A Leading Oncology Company By Advancing Its Immunotherapy Products And Expanding Its Portfolio Through Strategic Partnerships And Acquisitions
